In the subgroup analysis, being female (adjusted OR=2.273, 95% CI 0.933–5.199, P = 0.051) and taking antiplatelet drug (adjusted OR = 2.301, 95% CI 0.997–5.311, P = 0.051) was marginally significant with a poor functional outcome ( Supplementary Figure S2 ).
← all excerpts
Association of Uric Acid, High-Sensitivity C-Reactive Protein, and 90-Day Risk of Poor Function Outcome in Patients with Ischemic Stroke or Transient Ischemic Attacks.
1
—
—